Skip to main content
Fig. 1 | Virology Journal

Fig. 1

From: Responses of primary human nasal epithelial cells to EDIII-DENV stimulation: the first step to intranasal dengue vaccination

Fig. 1

Viability of HNEpCs treated with TMC NPs or EDIII-D3 TMC NPs. HNEpCs were treated with TMC NPs or EDIII-D3 TMC NPs at concentrations of 25 to 150 μg for 2 days. Cell viability was monitored using the trypan blue exclusion assay. The results obtained were compared with that of the untreated cultures. All values are represented as mean ± SD

Back to article page
\